Safety Study In Patients Who Were Born Small And Short And Were Treated With Growth Hormone To Achieve Normal Height

- Patients with SGA treated with growth hormone in one of the following Genotropin
studies (89-041, 89-070/071, 90-079, 90-080/98-8122-011) for at least 3 years and
after having stopped GH treatment for 5-10 years

- Untreated SGA (based on birth weight and/or length below -2 standard deviations [SDs]
for gestational age) matched to treated SGA by body mass index (+ or = 10%) and
gender:

- Subjects born SGA with normal final height (within +/- 1.3 SD of their target
height); or

- Subjects born SGA with short stature (height SDs > 1.3 below target at final
height).